• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Stocks

Jim Cramer: Abbott's Rapid Covid-19 Test and My Super Bowl Dreams

Abbott Labs can bring back some normalcy to this country -- and the world -- with its BinaxNOW rapid antigen test along with its amazing Navica app.
By JIM CRAMER
Sep 24, 2020 | 06:47 AM EDT
Stocks quotes in this article: ABT, SNY, GSK, JNJ, CVS, LUV, DIS

You can wait for the vaccine. Be my guest. I hope we have something by the end of the first quarter of 2021.

I don't think we can wait that long. Which is why I hope that Abbott Labs (ABT) can bring back some normalcy to this country -- and the world -- with its BinaxNOW rapid antigen test for Covid-19 along with its amazing Navica app that shows if you are safe to be admitted to where you want to go.

Look, I am a huge believer in the hoped-for vaccine. I am speaking to Sanofi (SNY) today about their incredible partnership with sworn competitor GlaxoSmithKline (GSK) about their efforts. I am trying to get into the Johnson & Johnson (JNJ) trial that was announced just yesterday.

But let's face it: we can't just presume that a vaccine works if a couple of thousand people are walking around in a bunch of cities for two months and they don't come down with anything. And we also can no longer presume that even if it seems to work anyone will take it because the darned thing's gotten so politicized. That's how unreliable the whole federal medical apparatus has become.

Which brings me back to Abbott's recently announced rapid test and its really cool Navica app that I have downloaded for free. Right now it is hard to find this 15-minute test because the federal government has procured 150 million of them to start the process of opening America with a higher degree of confidence than we currently have. That's about all that's available of this simple test that's done on premises instead of sending it out to some faraway lab for results.

It's pretty easy. A clinician takes a nasal swab, wipes it on a card and in 15 minutes you know if you are positive or negative for Covid-19. The results are then downloaded to your Navica app and a QR code tells you whether you have Covid or not within a 97% accuracy rate. It becomes your easily scanned cellphone test about whether you can enter or not and it is a heck of a lot more meaningful than a temperature take which you could argue may be for show because many really really sick people with Covid don't have temperature.

I believe the federal government wants to be able to test kids so they can go school or be turned back if their code shows positive. Obviously, you would keep your child back if she tested positive. The good news would be that both spouses could return to work -- no one would have to make the sad choice between a child's health and their own financial well-being. I think it is the most important priority out there right now.

Once Abbott Labs gets fully up to speed, though -- and they are spending hundreds of millions of dollars and hiring thousands of people to mass produce these kits --  the government won't be the only ones with tests. The drug stores can take over and really make this a mass product.

Here's how I see things shaking out. I know that the most impossible thing I am going to say tonight is that the Eagles will be in the Super Bowl.

Of course, I would go, Covid or not, because I am a total knucklehead Bird fanatic.

What I would envision is that by Super Bowl weekend in February everyone would have downloaded Navica and the airlines and stadiums will all have Navica screeners. The day before I go to the airport to fly to Tampa Bay, I will go to my CVS (CVS) after work and get my non-invasive 15-minute test with the results uploaded into my Navica app. I know you might have heard that you have to have some reason that you think you need to take the test. I think we have plenty of reasons so I am not worried about being rejected. You shouldn't be either. You won't be. I'll have my results, in my Navica, by the time I get home.

The next day I am going to go to the airport and just like I use my QR as an e-ticket to get on the plane, the airline will have a QR scanner to get your Navica verdict. If I am negative I will get on the plane. When I get to the stadium they, too, will scan my Navica and, again, I will get in to the game to see the Eagles probably beat the Patriots for the second time in three years.

Now, there's a catch. The test is only 97% effective. So you still want to wear a mask. But isn't 97% of something better than 100% of nothing? Oh, and after we win? I'm going to Disney World, where, by then, they, too, will have Navica readers so there's no tests, no line, and I am right into the Magic Kingdom.

The odd thing? I seem to be the only one who knows this will be the future. Gary Kelly, CEO of Southwest Airlines (LUV) , didn't know about it when I asked him yesterday. I don't know if Disney (DIS) has figured it out either. Suffice it to say I see the future they don't. Get ready for it. It's a lot more likely than a victory by the Eagles in the Super Bowl.

(Abbott Labs, Johnson & Johnson, Disney and CVS are holdings in Jim Cramer's Action Alerts PLUS member club. Want to be alerted before Jim Cramer buys or sells these stocks? Learn more now.)

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Action Alerts PLUS, which Cramer manages as a charitable trust, is long ABT, JNJ, DIS and CVS.

TAGS: Drug Approvals | Investing | Markets | Politics | Stocks | Trading | Healthcare | Pharmaceuticals | U.S. Equity |

More from Stocks

The Psilocybin Patent Race Is On

Debra Borchardt
Mar 6, 2021 12:30 PM EST

It feels like these companies are casting a wide net, but it makes sense to file at the beginning of this mushroom mania.

The Challenge of Short Selling

James "Rev Shark" DePorre
Mar 6, 2021 10:00 AM EST

Short selling is a powerful tool, but it is not just the inverse of going long and requires a very different mindset to do it effectively.

Kass: There Are Many Reasons to Be a Bear

Doug Kass
Mar 6, 2021 8:15 AM EST

I believe the markets are headed lower - probably not in a straight line or as steep as the last few days, but in a saw tooth fashion lower.

Bounce Takes Some of the Sting Out of a Painful Week

James "Rev Shark" DePorre
Mar 5, 2021 4:51 PM EST

It is premature to declare that the worst is over, but the intensity of the selling will go a long way toward helping a bottom to form.

The Selloff in Twilio Could Extend Deeper Into March

Bruce Kamich
Mar 5, 2021 2:30 PM EST

TWLO could bounce in the short-run but avoid the long side for now.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 11:38 AM EST GARY BERMAN

    The INDU and DIA

    FIBOCALL: The INDU index and the DIA The INDU ...
  • 10:44 AM EST JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    "The Challenge of Short-Selling"
  • 08:40 AM EST PAUL PRICE

    Recent Pick SpartanNash (SPTN) Raised Its Quarterly Payout by 3.9%

  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login